Corneal Confocal Microscopy to Image Small Nerve Fiber Degeneration: Ophthalmology Meets Neurology.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing literature without systematic review methodology
PubMed 35295436 · doi:10.3389/fpain.2021.725363
What was done
This narrative review evaluated the diagnostic and prognostic utility of corneal confocal microscopy (CCM)—a rapid, non-invasive ophthalmic imaging technique—for assessing small nerve fiber damage and regeneration in various peripheral neuropathies and central neurodegenerative conditions.
What was found
The abstract reports no numerical data, effect sizes, or test accuracy statistics. Descriptively, it states that CCM demonstrates diagnostic utility comparable to intraepidermal nerve fiber density in diabetic neuropathy, fibromyalgia, and amyloid neuropathy; predicts diabetic neuropathy onset; detects early nerve regeneration before symptom improvement in diabetic and sarcoid neuropathy trials; and identifies nerve fiber loss associated with disease progression in multiple sclerosis, Parkinson's disease, and dementia.
Why it matters
CCM offers a non-invasive ophthalmic approach to directly visualize small nerve fiber pathology, serving as a candidate surrogate endpoint for clinical trials and monitoring in neurodegenerative disorders.
Limits
As a narrative review, it lacks a systematic search strategy, risk-of-bias evaluation, and quantitative meta-analysis. No sample sizes, effect sizes, or diagnostic performance numbers (e.g., sensitivity, specificity) are provided in the abstract.
Cited by
- supports Corneal confocal microscopy can be used to image sensory nerves live and in real time in humans or animals to measure nerve degeneration and regeneration.